TrialAIDS (London, England)2014

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.

Nathan Clumeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.